Form 4: Coherent Corp. Director Exercises Stock Options and Sells Shares
Insider Transaction Report
Coherent Corp. Director Shaker Sadasivam exercised multiple tranches of stock options and subsequently sold a significant portion of the acquired common stock.
Summary
- Shaker Sadasivam, a Director at Coherent Corp. (COHR), executed several transactions on June 3, 2025, involving the exercise of stock options and the sale of common stock.
- He exercised options to acquire a total of 24,772 shares of common stock from four different tranches with varying exercise prices and vesting dates.
- Specifically, 9,240 shares were acquired at $21.67, 5,700 shares at $35.25, 4,020 shares at $49.90, and 5,812 shares at $36.56.
- Following the option exercises, Mr. Sadasivam sold 29,292 shares of Coherent Corp. common stock at a price of $80.00 per share.
- After these transactions, Mr. Sadasivam's direct beneficial ownership in Coherent Corp. common stock stands at 38,622 shares.
- The filing also includes a Substitute Power of Attorney dated March 18, 2025, appointing Aaron Wax, Chris Forrester, and Yian Huang as substitute attorneys-in-fact for SEC filings on behalf of several individuals, including Shaker Sadasivam.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the exercise of vested stock options and the subsequent sale of common stock. While the sale reduces insider ownership, it's a common financial planning activity for executives, especially given the profitable sale price, and does not inherently indicate a positive or negative outlook for the company's operations.
Positives
- The director realized significant profit by selling shares at $80.00, substantially higher than the exercise prices ranging from $21.67 to $49.90.
- The exercise of vested options is a normal part of executive compensation and indicates the realization of long-term incentives.
Negatives
- The sale of 29,292 shares by a director reduces insider ownership, which can sometimes be perceived negatively by the market, especially since the number of shares sold exceeded the number of shares acquired through exercise.
Future Outlook
This document does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing pertains to an individual insider transaction and does not provide information on broader industry trends or competitive landscape.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-Fact | Jeffrey W. Acre | Aaron Wax | 03/18/2025 | Appointment as substitute attorney-in-fact with full power of substitution for SEC filings. |
| Attorney-in-Fact | Jeffrey W. Acre | Chris Forrester | 03/18/2025 | Appointment as substitute attorney-in-fact with full power of substitution for SEC filings. |
| Attorney-in-Fact | Jeffrey W. Acre | Yian Huang | 03/18/2025 | Appointment as substitute attorney-in-fact with full power of substitution for SEC filings. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Appointment of Aaron Wax, Chris Forrester, and Yian Huang as substitute attorneys-in-fact to execute Forms 3, 4, and 5 on behalf of specified individuals, including directors and officers, for Section 16(a) compliance. | 03/18/2025 | Ensures continued and efficient compliance with SEC reporting requirements for insider transactions by delegating authority to new administrative personnel. |
Stakeholder Impact
- Shareholders: May observe a reduction in insider ownership due to the share sale, but the transaction is a common financial planning activity for executives and reflects the realization of value from vested options.
Key Dates
| Date | Description |
|---|---|
| 08/20/2017 | Vesting start date for 9,240 stock options. |
| 08/18/2018 | Vesting start date for 5,700 stock options. |
| 08/28/2019 | Vesting start date for 4,020 stock options. |
| 08/28/2020 | Vesting start date for 5,812 stock options. |
| 03/18/2025 | Execution date of the Substitute Power of Attorney. |
| 06/03/2025 | Date of stock option exercise and common stock sale transactions by Shaker Sadasivam. |
| 06/05/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
COHERENT CORP., COHR, Form 4, insider trading, stock options, beneficial ownership, director transactions, share sale, executive compensation, Power of Attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.